CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C12504 | BRD-K31825071 | BRD-K31825071 | -- | -- | -- | Details |
| C12505 | BRD-K31826120 | BRD-K31826120 | -- | -- | -- | Details |
| C12506 | BRD-K31828306 | BRD-K31828306 | -- | -- | -- | Details |
| C12507 | BRD-K31829694 | BRD-K31829694 | -- | -- | -- | Details |
| C12508 | BRD-K31830150 | SA-1460224 | -- | -- | -- | Details |
| C12509 | BRD-K31830316 | BRD-K31830316 | -- | -- | -- | Details |
| C12510 | BRD-K31830662 | BRD-K31830662 | -- | -- | -- | Details |
| C12511 | BRD-K31834149 | BRD-K31834149 | -- | -- | -- | Details |
| C12512 | BRD-K31836496 | BRD-K31836496 | -- | -- | -- | Details |
| C12513 | BRD-K31836715 | fisetin | CDK6 | Aurora kinase inhibitor | -- | Details |
| C12514 | BRD-K31841256 | BRD-K31841256 | -- | -- | -- | Details |
| C12515 | BRD-K31841515 | oxypurinol | XDH | Xanthine oxidase inhibitor | -- | Details |
| C12516 | BRD-K31843556 | T-0070907 | PPARG | PPAR receptor antagonist | -- | Details |
| C12517 | BRD-K31844308 | BRD-K31844308 | -- | -- | -- | Details |
| C12518 | BRD-K31844452 | BRD-K31844452 | -- | -- | -- | Details |
| C12519 | BRD-K31846842 | BRD-K31846842 | -- | -- | -- | Details |
| C12520 | BRD-K31851055 | BRD-K31851055 | -- | -- | -- | Details |
| C12521 | BRD-K31851742 | BRD-K31851742 | -- | -- | -- | Details |
| C12522 | BRD-K31852848 | BRD-K31852848 | -- | -- | -- | Details |
| C12523 | BRD-K31856043 | BRD-K31856043 | -- | -- | -- | Details |
| C12524 | BRD-K31866446 | BRD-K31866446 | -- | -- | -- | Details |
| C12525 | BRD-K31869770 | BRD-K31869770 | -- | -- | -- | Details |
| C12526 | BRD-K31870622 | BRD-K31870622 | -- | -- | -- | Details |
| C12527 | BRD-K31874013 | BRD-K31874013 | -- | -- | -- | Details |
| C12528 | BRD-K31874833 | diallyl-phthalate | -- | -- | -- | Details |
| C12529 | BRD-K31877241 | BRD-K31877241 | -- | -- | -- | Details |
| C12530 | BRD-K31883641 | BRD-K31883641 | -- | -- | -- | Details |
| C12531 | BRD-K31883758 | BRD-K31883758 | -- | -- | -- | Details |
| C12532 | BRD-K31883841 | BRD-K31883841 | -- | -- | -- | Details |
| C12533 | BRD-K31883990 | BRD-K31883990 | -- | -- | -- | Details |
| C12534 | BRD-K31884664 | BRD-K31884664 | -- | -- | -- | Details |
| C12535 | BRD-K31887147 | BRD-K31887147 | -- | -- | -- | Details |
| C12536 | BRD-K31889353 | BRD-K31889353 | -- | -- | -- | Details |
| C12537 | BRD-K31896531 | BRD-K31896531 | -- | -- | -- | Details |
| C12538 | BRD-K31897694 | BRD-K31897694 | -- | -- | -- | Details |
| C12539 | BRD-K31898235 | BRD-K31898235 | -- | -- | -- | Details |
| C12540 | BRD-K31898736 | BRD-K31898736 | -- | -- | -- | Details |
| C12541 | BRD-K31899031 | citral | -- | -- | -- | Details |
| C12542 | BRD-K31900068 | BRD-K31900068 | -- | -- | -- | Details |
| C12543 | BRD-K31903015 | BRD-K31903015 | -- | -- | -- | Details |
| C12544 | BRD-K31906558 | BRD-K31906558 | -- | -- | -- | Details |
| C12545 | BRD-K31908823 | BRD-K31908823 | -- | -- | -- | Details |
| C12546 | BRD-K31912990 | CGP-71683 | NPY5R | Neuropeptide receptor antagonist | -- | Details |
| C12547 | BRD-K31917106 | BRD-K31917106 | -- | -- | -- | Details |
| C12548 | BRD-K31920348 | BRD-K31920348 | -- | -- | -- | Details |
| C12549 | BRD-K31920458 | mestranol | ESR1 | Estrogen receptor agonist | -- | Details |
| C12550 | BRD-K31921933 | BRD-K31921933 | -- | -- | -- | Details |
| C12551 | BRD-K31928320 | BRD-K31928320 | -- | -- | -- | Details |
| C12552 | BRD-K31928526 | barasertib | AURKA; AURKB | Aurora kinase inhibitor | -- | Details |
| C12553 | BRD-K31929173 | SA-1472514 | -- | -- | -- | Details |
| C12554 | BRD-K31931379 | BRD-K31931379 | -- | -- | -- | Details |
| C12555 | BRD-K31931684 | BRD-K31931684 | -- | -- | -- | Details |
| C12556 | BRD-K31933349 | BRD-K31933349 | -- | -- | -- | Details |
| C12557 | BRD-K31933523 | BRD-K31933523 | -- | -- | -- | Details |
| C12558 | BRD-K31936306 | BRD-K31936306 | -- | -- | -- | Details |
| C12559 | BRD-K31939603 | BRD-K31939603 | -- | -- | -- | Details |
| C12560 | BRD-K31949858 | BRD-K31949858 | -- | -- | -- | Details |
| C12561 | BRD-K31952722 | BRD-K31952722 | -- | -- | -- | Details |
| C12562 | BRD-K31955163 | BRD-K31955163 | -- | -- | -- | Details |
| C12563 | BRD-K31960013 | BRD-K31960013 | -- | -- | -- | Details |
| C12564 | BRD-K31965398 | aclarubicin | TOP1; TOP2A | Topoisomerase inhibitor | -- | Details |
| C12565 | BRD-K31969867 | BRD-K31969867 | -- | -- | -- | Details |
| C12566 | BRD-K31970894 | BRD-K31970894 | -- | -- | -- | Details |
| C12567 | BRD-K31975688 | BRD-K31975688 | -- | -- | -- | Details |
| C12568 | BRD-K31977946 | BRD-K31977946 | -- | -- | -- | Details |
| C12569 | BRD-K31987278 | BRD-K31987278 | -- | -- | -- | Details |
| C12570 | BRD-K31987754 | oleylethanolamide | GPR119 | Potassium channel blocker; Cannabinoid receptor agonist; Glucose dependent insulinotropic receptor agonist | -- | Details |
| C12571 | BRD-K31992830 | BRD-K31992830 | -- | -- | -- | Details |
| C12572 | BRD-K31992949 | BRD-K31992949 | -- | -- | -- | Details |
| C12573 | BRD-K31994521 | BRD-K31994521 | -- | -- | -- | Details |
| C12574 | BRD-K31998493 | BRD-K31998493 | -- | -- | -- | Details |
| C12575 | BRD-K31999759 | BRD-K31999759 | -- | -- | -- | Details |
| C12576 | BRD-K32000549 | BRD-K32000549 | -- | -- | -- | Details |
| C12577 | BRD-K32010074 | MW-A1-14 | -- | -- | -- | Details |
| C12578 | BRD-K32014638 | BRD-K32014638 | -- | -- | -- | Details |
| C12579 | BRD-K32015301 | BRD-K32015301 | -- | -- | -- | Details |
| C12580 | BRD-K32018176 | BRD-K32018176 | -- | -- | -- | Details |
| C12581 | BRD-K32019201 | BRD-K32019201 | -- | -- | -- | Details |
| C12582 | BRD-K32021043 | sulfachlorpyridazine | -- | -- | -- | Details |
| C12583 | BRD-K32021110 | BRD-K32021110 | -- | -- | -- | Details |
| C12584 | BRD-K32021722 | BRD-K32021722 | -- | -- | -- | Details |
| C12585 | BRD-K32027259 | BRD-K32027259 | -- | -- | -- | Details |
| C12586 | BRD-K32030161 | BRD-K32030161 | -- | -- | -- | Details |
| C12587 | BRD-K32035967 | BRD-K32035967 | -- | -- | -- | Details |
| C12588 | BRD-K32037893 | BRD-K32037893 | -- | -- | -- | Details |
| C12589 | BRD-K32040163 | BRD-K32040163 | -- | -- | -- | Details |
| C12590 | BRD-K32040515 | BRD-K32040515 | -- | -- | -- | Details |
| C12591 | BRD-K32043164 | VU-0415012 | -- | -- | -- | Details |
| C12592 | BRD-K32043305 | BRD-K32043305 | -- | -- | -- | Details |
| C12593 | BRD-K32048092 | BRD-K32048092 | -- | -- | -- | Details |
| C12594 | BRD-K32049721 | BRD-K32049721 | -- | -- | -- | Details |
| C12595 | BRD-K32049912 | BRD-K32049912 | -- | -- | -- | Details |
| C12596 | BRD-K32051704 | BRD-K32051704 | -- | -- | -- | Details |
| C12597 | BRD-K32052120 | isopropanol | -- | -- | -- | Details |
| C12598 | BRD-K32053117 | BRD-K32053117 | -- | -- | -- | Details |
| C12599 | BRD-K32053286 | BRD-K32053286 | -- | -- | -- | Details |
| C12600 | BRD-K32063762 | BRD-K32063762 | -- | -- | -- | Details |
| C12601 | BRD-K32066855 | BRD-K32066855 | -- | -- | -- | Details |
| C12602 | BRD-K32068846 | BRD-K32068846 | -- | -- | -- | Details |
| C12603 | BRD-K32069250 | BRD-K32069250 | -- | -- | -- | Details |